These uses are based on published scientific literature on GHK-Cus biological activity
Local Reactions: Redness, swelling, itching, or pain at the subcutaneous injection site
Conversely, equivalent residues in GCGR (I194 2.67b and S297 ECL2 ) are unable to form these hydrogen bonds
These drugs, known as glucagon-like peptide-1 receptor agonists or GLP-1 medications, have gained attention for their role in helping people manage type 2 diabetes, and more recently, for their weight loss benefits
Hypoglycaemic Episodes Eight of the 15 studies (totalling 14 patients) demonstrated no episodes of hypoglycaemia after treatment with a GLP-1 RA [16, 17, 21,22,23,24,25,26]